History

Leading the biomarket with human-derived cell-penetrating peptides

Continuously researching
to innovate and develop our technologies

2023-2024

Peptide technology research and commercialization

  • 2024

    • 05
      • Selected as a global corporate collaboration program for government tasks
    • 03
      • Export voucher selection
  • 2023

    • 06
      • Selected as a government task manufacturing venture company technology development project
    • 04
      • Domestic patent application and international patent application
      • 피부 미백 활성을 가지는 펩타이드를 포함하는 조성물
    • 03
      • Domestic patent application and international patent application
      • 화물분자 수송 도메인 RMMR1, 이의 변이체, 재조합 화물분자 및 이를 이용한 화물분자 수송 방법
    • 01
      • Domestic patent application and international patent application
      • 화물분자 수송 도메인 RMAD1, 이의 변이체, 재조합 화물분자 및 이를 이용한 화물분자 수송 방법

2022

Establishment of research institute and peptide research

  • 2022

    • 10
      • Domestic patent application and international patent application
      • 상처 치료 및 항염증 활성을 가지는 펩타이드 및 이의 용도 아토피 피부염 예방 또는 치료 활성을 가지는 펩타이드
    • 06
      • Registered as a venture business
    • 05
      • Selected as a stepping stone for start-up growth as a government project
    • 04
      • Registered as LMO level 2 research facility
    • 02
      • Registered as a performance sharing company
      • Sign up for tomorrow’s Chaeum deduction
      • BioNT Co., Ltd. MOU agreement
    • 01
      • Establishment of REMEDI Co., Ltd.’s research center

2020-2021

Establishment of REMEDI and development of IDDT platform

  • 2021

    • 12
      • Registered as a mail order business
    • 04
      • Establishment of a department dedicated to aging research
    • 01
      • Registered as a responsible sales business for cosmetics
      • Registered as a cosmetics manufacturing company
  • 2020

    • 11
      • Establishment of REMEDI Co., Ltd.
Since 2020